MaxLinear, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) Per Share

Net Income (Loss) Per Share

9 Months Ended

Sep. 30, 2025

Basic earnings per share, or EPS, is calculated by dividing net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net loss by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.

The table below presents the computation of basic and diluted EPS:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
	(in thousands, except per share amounts)
Numerator:
Net loss	$	(45,485)	$	(75,785)	$	(121,784)	$	(187,360)
Denominator:
Weighted average common shares outstanding—basic	87,186		84,074		86,368		83,303
Dilutive common stock equivalents	—		—		—		—
Weighted average common shares outstanding—diluted	87,186		84,074		86,368		83,303
Net loss per share:
Basic	$	(0.52)	$	(0.90)	$	(1.41)	$	(2.25)
Diluted	$	(0.52)	$	(0.90)	$	(1.41)	$	(2.25)

For the three months ended September 30, 2025 and 2024, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 4.5 million and 6.0 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.

For the nine months ended September 30, 2025 and 2024, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 5.8 million and 6.2 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.